Grigorios Korosoglou | Health Professions | Best Paper Award

Best Paper Award

State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach

Grigorios Korosoglou
Affiliation GRN Hospital Weinheim
Country Germany
Article Title State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach
Scopus ID 6507894424
Article Type Review Article
Article Views 1102
Reference Count 34
Award Category Best Paper Award
Event International Research Excellence and Best Paper Awards
ORCID 0000-0002-6038-2253

The Best Paper Award recognizes the scholarly contribution of Grigorios Korosoglou for the publication titled State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach. The article contributes to contemporary cardiovascular and vascular intervention research by examining evidence-based treatment pathways for femoropopliteal lesions and presenting a structured clinical decision framework. The work reflects the integration of clinical expertise, systematic evaluation, and translational application within health professions research, supporting improved patient management and procedural outcomes in vascular medicine.[1]

Abstract

This award-recognized article examines definitive treatment strategies for femoropopliteal arterial lesions through a structured case-based framework. The study evaluates current endovascular and adjunctive therapeutic approaches, emphasizing lesion characteristics, patient-specific risk factors, procedural planning, and long-term vessel patency. By integrating contemporary evidence with clinical decision-making principles, the publication provides guidance for selecting appropriate interventions in complex peripheral artery disease cases. The work highlights evolving technologies, procedural optimization, and outcome assessment while supporting individualized treatment pathways. Its findings contribute to improved understanding of therapeutic selection and clinical management within modern vascular medicine and cardiovascular intervention practice.[2]

Keywords

Definitive Lesion Treatment; Case-Based Approach; Femoropopliteal Lesions; Chronic Total Occlusions (CTOs); Drug-Coated Balloon Angioplasty (DCB); Bare-Metal Stents (BMSs); Drug Eluting Stents (DESs); Interwoven Stents.

Introduction

Peripheral artery disease remains a significant contributor to morbidity worldwide, particularly among aging populations and individuals with cardiovascular risk factors. Femoropopliteal lesions present unique treatment challenges because of vessel movement, lesion complexity, and the need for durable long-term outcomes. Contemporary research increasingly focuses on refining therapeutic strategies that balance procedural success, patient safety, and sustained vascular patency while incorporating advances in endovascular technologies and evidence-based clinical practice.[3]

Research Profile

Grigorios Korosoglou is affiliated with GRN Hospital Weinheim and has established a substantial academic profile within cardiovascular and health professions research. According to available scholarly metrics, the researcher has authored numerous publications, accumulated significant citation impact, and achieved a notable h-index. The recognized publication reflects continued engagement with translational clinical research aimed at improving diagnostic and therapeutic approaches in vascular medicine.[1]

Scientific Background

The management of femoropopliteal disease has evolved considerably through advances in imaging, device technology, and procedural techniques. Clinical investigations have demonstrated that lesion morphology, calcification, vessel diameter, and patient comorbidities significantly influence therapeutic outcomes. Research in this field seeks to optimize intervention selection while minimizing restenosis, repeat procedures, and adverse events. Consequently, systematic treatment frameworks have become increasingly important for supporting consistent and evidence-informed clinical decisions.[2]

Methodology

The publication employs a case-based systematic approach to evaluate treatment pathways for femoropopliteal lesions. Clinical scenarios are used to illustrate decision-making processes, integrating current evidence, procedural considerations, lesion assessment, and patient-specific characteristics. This methodology enables practical interpretation of available research findings while demonstrating how contemporary therapeutic options can be applied in real-world clinical environments. The approach supports both educational and clinical objectives by linking evidence with application.[2]

Key Findings

The study emphasizes that successful treatment selection depends on comprehensive lesion characterization and individualized patient evaluation. Findings indicate that modern endovascular technologies offer expanded therapeutic possibilities when integrated into structured treatment algorithms. The article further highlights the importance of balancing procedural efficiency with long-term clinical outcomes, reinforcing the value of evidence-guided intervention planning for achieving durable vascular results and improved patient care.[4]

Scientific Contributions

This publication contributes to vascular medicine by consolidating current knowledge into a clinically accessible framework that supports treatment selection for femoropopliteal disease. The article bridges scientific evidence and clinical implementation, offering insights into procedural planning, patient stratification, and therapeutic optimization. Its systematic perspective enhances understanding of contemporary intervention strategies while promoting informed decision-making across diverse healthcare settings and patient populations.[4]

Conclusion

The award-winning article provides a comprehensive examination of definitive femoropopliteal lesion treatment strategies within a modern clinical context. Through its case-based and evidence-oriented methodology, the work supports effective therapeutic decision-making and highlights the importance of individualized patient care. The publication represents a meaningful contribution to health professions research and advances ongoing efforts to improve outcomes in peripheral vascular disease management.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Grigorios Korosoglou, Author ID 6507894424. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507894424
  2. Korosoglou, G. (2026). State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach. Journal of Cardiovascular Development and Disease.
    https://doi.org/10.3390/jcdd13040150
  3. MDPI. (2026). Journal of Cardiovascular Development and Disease.
    https://www.mdpi.com/journal/jcdd
  4. Atherectomy Followed by Drug-Coated Balloon Angioplasty Versus Surgery for Symptomatic Deep Femoral Artery Arteriosclerotic Disease.
    https://doi.org/10.1177/15266028241284443
  5. International Research Excellence and Best Paper Awards. (2026). Award Recognition Information.
    https://bestpaperawards.com/

Douâae Ou-Yahia | Immunology and Microbiology | Editorial Board Member

Dr. Douâae Ou-Yahia | Immunology and Microbiology | Editorial Board Member 

Chercheur associé | Sidi Mohamed Ben Abdellah University | Morocco

Douâae Ou-Yahia is a researcher whose work primarily focuses on the bioactive properties and pharmacological potential of plant-derived compounds, particularly essential oils and polyphenols from Moroccan flora. Her research encompasses the evaluation of antioxidant, antimicrobial, cytotoxic, and genotoxic effects of various plant extracts, with a strong emphasis on discovering novel therapeutic agents, especially against breast cancer. In 2023, she co-authored several notable studies, including investigations into Ptychotis verticillata essential oil, demonstrating its antioxidant activity and potential as a breast cancer therapeutic, and studies on Mentha piperita, exploring how irrigation water quality affects its chemical profile and secondary metabolites, with implications for pharmacological applications. She has also extensively studied carob (Ceratonia siliqua var. Rahma) leaves, analyzing their polyphenol content, antimicrobial activity, cytotoxicity against cancer cell lines, and genotoxicity, highlighting their multi-faceted potential as functional bioactive compounds. Her research combines both in vitro and in silico approaches, integrating analytical profiling, chemical characterization, and computational modeling to better understand plant bioactivity and optimize therapeutic applications. Beyond her laboratory work, Douâae Ou-Yahia contributes to advancing the scientific understanding of medicinal plants in Morocco, providing insights that may support the development of natural and effective treatments. Her publications, appearing in journals such as Life, International Journal of Plant Biology, Pharmaceuticals, and Antibiotics, reflect a commitment to rigorous experimental design and multidisciplinary collaboration with other experts in the fields of pharmacology, chemistry, and plant biology. Overall, her work bridges fundamental phytochemical research and applied biomedical science, offering promising avenues for natural product-based therapies and contributing to global efforts in exploring sustainable, plant-based solutions for healthcare challenges.

Profile: ORCID

Featured Publications

  1. Taibi, M., Elbouzidi, A., Ouahhoud, S., Loukili, E. H., Ou-Yahia, D., Ouahabi, S., Alqahtani, A. S., Noman, O. M., Addi, M., Bellaouchi, R., et al. (2023). Evaluation of antioxidant activity, cytotoxicity, and genotoxicity of Ptychotis verticillata essential oil: Towards novel breast cancer therapeutics. Life, 13(7), 1586.

  2. Haddou, M., Taibi, M., Elbouzidi, A., Loukili, E. H., Yahyaoui, M. I., Ou-Yahia, D., Mehane, L., Addi, M., Asehraou, A., Chaabane, K., et al. (2023). Investigating the impact of irrigation water quality on secondary metabolites and chemical profile of Mentha piperita essential oil: Analytical profiling, characterization, and potential pharmacological applications. International Journal of Plant Biology, 14(3), 49.

  3. Elbouzidi, A., Taibi, M., Ouassou, H., Ouahhoud, S., Ou-Yahia, D., Loukili, E. H., Aherkou, M., Mansouri, F., Bencheikh, N., Laaraj, S., et al. (2023). Exploring the multi-faceted potential of carob (Ceratonia siliqua var. Rahma) leaves from Morocco: A comprehensive analysis of polyphenols profile, antimicrobial activity, cytotoxicity against breast cancer cell lines, and genotoxicity. Pharmaceuticals, 16(6), 840.

  4. Taibi, M., Elbouzidi, A., Ou-Yahia, D., Dalli, M., Bellaouchi, R., Tikent, A., Roubi, M., Gseyra, N., Asehraou, A., Hano, C., et al. (2023). Assessment of the antioxidant and antimicrobial potential of Ptychotis verticillata Duby essential oil from Eastern Morocco: An in vitro and in silico analysis. Antibiotics, 12(4), 655.

  5. Elbouzidi, A., Taibi, M., Ou-Yahia, D., Loukili, E. H., & others. (2023). Exploring the multi-faceted potential of carob leaves from Morocco: A comprehensive analysis of polyphenols profile, antimicrobial activity, cytotoxicity against breast cancer cell lines, and genotoxicity. Preprint.

Douâae Ou-Yahia’s research advances the understanding of bioactive compounds from Moroccan plants, providing novel insights into natural antioxidants, antimicrobials, and cancer therapeutics. Her work bridges fundamental phytochemistry and applied biomedical science, contributing to healthcare innovation and sustainable, plant-based solutions with global impact.

Zaid Khan | Health Professions | Best Researcher Award

Dr. Zaid Khan | Health Professions | Best Researcher Award

Pharm D Intern | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a passionate and accomplished young researcher in the field of pharmaceutical and clinical sciences, demonstrating a rare blend of academic excellence, research depth, and innovative drive at the age of 24. He is currently pursuing his Doctor of Pharmacy (Pharm.D.) degree at Aditya Bangalore Institute of Pharmacy Education and Research, affiliated with Rajiv Gandhi University of Health Sciences, Karnataka, India (2019–2025). His educational background has provided him with a strong foundation in clinical pharmacology, pharmacovigilance, and drug discovery. Professionally, Dr. Khan has undertaken significant research and clinical internships, including his role as a Clinical Pharmacist Intern at Akash Super Specialty Hospital, where he gained hands-on experience in medication therapy management, pharmacovigilance, and patient-centered care. His research interests span antibiotic stewardship, gene therapy, oncology, digital health integration, and AI-based precision medicine. He has published more than 19 research and review articles indexed in Scopus, PubMed, and Google Scholar, and holds a design patent for a Blood Cancer Detection Device granted by the Government of India. His research skills include data analysis, statistical interpretation, in-silico modeling, clinical documentation, and interdisciplinary collaboration. Dr. Khan also serves on the editorial boards of reputed STM journals such as the International Journal of Membranes and the International Journal of Antibiotics, reflecting his growing leadership in scholarly publishing. His awards and honors include the InRes Young Researcher Award 2023, multiple national-level recognitions in pharmacovigilance, and top placements in research competitions and poster presentations. He is a life member of the Institute of Researchers (InRes) and an active member of the Indian Association of Pharmaceutical and Clinical Research Professionals (IAPCR). In conclusion, Dr. Zaid Khan’s academic achievements, research publications, innovative mindset, and commitment to advancing pharmaceutical science position him as a promising young researcher with significant potential to contribute to the future of clinical and translational medicine on a global scale.

Profiles: ORCID | LinkedIn

Featured Publications

  1. Khan, Z., & Hiremath, S. R. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 13(2), 93–100.

  2. Khan, Z., Rekha, M., & Shapur, S. (2025). Transforming postoperative recovery: Synergistic impact of medication therapy management and precision analgesia on patient outcomes. Journal of Pharmacology and Clinical Practice.

  3. Khan, Z. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

  4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple surgery. Research and Reviews: Journal of Oncology and Hematology, 13(1), 1–6.

  5. Khan, Z., Sajeev, N., & Ba, V. (2023). Enhancing sun protection: Formulating and assessing herbal sunscreen formulations. RGUHS Journal of Pharmaceutical Sciences, 13(4).